| Factor Information | |
|---|---|
| Data ID | 2544 |
| Factor | correlation between BNP with heart failure in all patients with Stage II |
| Description | BNP=B-type natriuretic peptide, Stage II=establishment of partial cavopulmonary circulation between superior vena cava and pulmonary arteries (e.g., Glenn shunt, Kawashima) |
| Biomarker | YES |
| Classification | Z (combined factor - combined factor) |
| Association | |
|---|---|
| Application | risk assessment and prognosis |
| Objective | The aim of the present study was to define the effect of SV morphology and stage of palliation on the correlation between BNP and HF. |
| p Value | 0.03 |
| OR | 1.5 |
| Conclusion | In conclusion, plasma BNP and NT-proBNP are reliable tests for clinical HF in young children with SV physiology, specifically those with right ventricular morphology, regardless of the stage of palliation. |
| Risk Factor | risk factor |
| CHD Type | |
|---|---|
| ID | 608 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | HLHS/MA/MS/AA/MS/AS/RDACD/DORV/IAA, VSD, SLV/AS, PS, LV/AS, L-TGA, PS, SLV/TA/PA, IVS/DILV/D-TGA, MV, RV/PS, RV |
| Reference | |
|---|---|
| PMID | 22196786 |
| Year | 2012 |
| Title | Usefulness of B-Type Natriuretic Peptide and N-Terminal Pro-B-Type Natriuretic Peptide as Biomarkers for Heart Failure in Young Children With Single Ventricle Congenital Heart Disease |
| Sample | ||
|---|---|---|
| Population | young children | |
| Source | patients' data | |
| Region | California, America | |
| Method | univariate logistic regression analysis | |
| Race | American | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | N/A(Treatment) | N/A(Control) |
| Number | N/A | N/A |
| Age | N/A | N/A |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | N/A | N/A |
